Agfa HealthCare reported second-quarter net sales of 365 million euros ($466 million U.S.), up 1.7% compared with the 359 million euros ($458 million) turned in during the second quarter of 2005.
For the period (end-June 30), the Mortsel, Belgium-based division had earnings before interest and tax (EBIT) of 51.2 million euros ($65.4 million), an impressive 43.4% gain compared with the 35.7 million euros ($45.6 million) of EBIT posted during the same quarter last year.
Agfa attributed the sales growth in the division to the performance of its healthcare IT activities, favorable currency effects, and its recently acquired Heartlab operations. Worldwide RIS, PACS, and electronic health record (EHR) orders were strong during the quarter, driven by U.K., Canadian, and European placements, the company said.
By AuntMinnie.com staff writers
August 24, 2006
Related Reading
Agfa lands UCSD RIS order, August 16, 2006
Agfa installs first Chinese Impax RIS, August 9, 2006
Agfa signs Australia cardiac center, August 8, 2006
Agfa lands Toronto regional PACS deal, July 14, 2006
Agfa signs Norwegian IT deal, July 5, 2006
Copyright © 2006 AuntMinnie.com
